1. Archer GE, Bigner DD, Friedman AH, Heimberger AB, Sampson J. Induction of CD4 and CD8 T cells to the tumor-specific antigen EGFRvIII. 15th International Conference on Brain Tumor Research and Therapy. Sorrento, Italy. May 24–27, 2003. [Abstract] Neuro-Oncology 2003;5:5.
2. Bloom HJ, Peckham MJ, Richardson AE, Alexander PA, Payne PM. Glioblastoma multiforme: a controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer 1973;27: 253–267.
3. Brooks WH, Markesbery WR, Gupta GD, Roszman TL. Relationship of lymphocyte invasion and survival of brain tumor patients. Ann Neurol 1978;4:219–224.
4. Cserr HF, DePasquale M, Harling-Berg CJ, Park JT, Knopf PM. Afferent and efferent arms of the humoral immune response to CSF-administered albumins in a rat model with normal blood-brain barrier permeability. J Neuroimmunol 1992; 41:195–202.
5. Dresemann G. Temozolomide/pegylated liposomal doxorubicin (PLD) in progressive glioblastoma multiforme (GBM). In: Abstracts from the World Federation of Neuro-Oncology Second Quadrennial Meeting and the Sixth Meeting of the European Association for Neuro-Oncology. May 5–8, 2005. Edinburgh, United Kingdom. [Abstract 112] Society of Neuro-Oncology, 2005:310.